Evidence map›Paper›PMID 29599909›Full record

ArticleOncotarget2018

RNA-binding protein AUF1 suppresses miR-122 biogenesis by down-regulating Dicer1 in hepatocellular carcinoma.

Xia Wu, Yingzhuo Yang, Yike Huang, Yang Chen, Tianying Wang, Shuo Wu, Lei Tong, Yan Wang, Lexun Lin, Meili Hao and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Rare Hereditary Gynecological Cancer Syndromes.International journal of molecular sciences · 2022
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Xia WuDepartment of Microbiology, Harbin Medical University, Harbin 150081, China.
Yingzhuo YangDepartment of Infectious Diseases, The Second Affiliated Hospital, Harbin Medical University, Harbin 150081, China.
Yike HuangDepartment of Microbiology, Harbin Medical University, Harbin 150081, China.
Yang ChenDepartment of Microbiology, Harbin Medical University, Harbin 150081, China.
Tianying WangDepartment of Microbiology, Harbin Medical University, Harbin 150081, China.
Shuo WuDepartment of Microbiology, Harbin Medical University, Harbin 150081, China.
Lei TongDepartment of Microbiology, Harbin Medical University, Harbin 150081, China.
Yan WangDepartment of Microbiology, Harbin Medical University, Harbin 150081, China.
Lexun LinDepartment of Microbiology, Harbin Medical University, Harbin 150081, China.
Meili HaoDepartment of Cell Biology, Harbin Medical University, Harbin 150081, China.
Zhao-Hua ZhongDepartment of Microbiology, Harbin Medical University, Harbin 150081, China.
Fengmin ZhangDepartment of Microbiology, Harbin Medical University, Harbin 150081, China.
Wenran ZhaoDepartment of Cell Biology, Harbin Medical University, Harbin 150081, China.
Harbin Medical University · CNSecond Affiliated Hospital of Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) is one of the common cancers worldwide, especially in developing countries. Although the chronic infections of hepatitis B and C viruses have been established as the etiological factors of HCC, the mechanism for the tumorigenesis and development of HCC is still unclear. The liver-specific microRNA-122 (miR-122), an established tumor-suppressor miRNA, is often down-regulated in HCC, while the underlying mechanism is not well understood. Here we report that the AU-rich element-binding factor AUF1 suppresses the expression of Dicer1, the type III RNase that is required for microRNA maturation, leading to the inhibited biogenesis of miR-122. Overexpression of AUF1 led to the decreased expression of Dicer1 and miR-122, while the level of the miR-122 precursor (pre-miR-122) was increased. On the other hand, siRNA of AUF1 (siAUF1) increased the levels of Dicer1 mRNA and miR-122, but it reduced the abundance of pre-miR-122. Consistent with the reported data, this study demonstrated that AUF1 and Dicer1 showed opposite expression pattern in both human HCC tissues and cell lines. In addition, AUF1 inhibited the expression of Dicer1 by interacting with the 3' untranslated region (3'UTR) and coding region of

Indexed as

AUF1Dicer1hepatocellular carcinomamicroRNA biogenesismiR-122

Identifiers

PMID29599909
PMCPMC5871080
OpenAlexW2783648497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.